{Reference Type}: Journal Article
{Title}: COVID-19: Ocular Manifestations and the APAO Prevention Guidelines for Ophthalmic Practices.
{Author}: Wong RLM;Ting DSW;Wan KH;Lai KHW;Ko CN;Ruamviboonsuk P;Huang SS;Lam DSC;Tham CCY;
{Journal}: Asia Pac J Ophthalmol (Phila)
{Volume}: 9
{Issue}: 4
{Year}: Jul-Aug 2020
{Factor}: 4.206
{DOI}: 10.1097/APO.0000000000000308
{Abstract}: The World Health Organization declared the Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 a "Pandemic" on March 11, 2020. As of June 1, 2020, Severe Acute Respiratory Syndrome Coronavirus 2 has infected >6.2 million people and caused >372,000 deaths, including many health care personnel. It is highly infectious and ophthalmologists are at a higher risk of the infection due to a number of reasons including the proximity between doctors and patients during ocular examinations, microaerosols generated by the noncontact tonometer, tears as a potential source of infection, and some COVID-19 cases present with conjunctivitis. This article describes the ocular manifestations of COVID-19 and the APAO guidelines in mitigating the risks of contracting and/or spreading COVID-19 in ophthalmic practices.